Axon Enterprise (AXON) 2025 — Grade F: CFFO -48%, Debt/EBITDA 9.7x

Grade: F — Major Red Flags

Framework: Schilit *Financial Shenanigans* + Beneish M-Score + forensic accounting principles

Data: SEC EDGAR 10-K (Filed 2026-02-25) + Yahoo Finance

Auditor: PricewaterhouseCoopers LLP (PCAOB ID No. 238) — Clean opinion

One-line verdict: Axon is a high-growth public safety technology platform with $2.8B in revenue (+34% YoY), but its earnings quality is deeply compromised by two structural problems: operating cash flow declined 48% while revenue surged 34% — a classic revenue-cash divergence red flag — and leverage is dangerously elevated at 9.7x Debt/EBITDA with negative interest coverage following the $1.75B Senior Notes issuance in March 2025. The Beneish M-Score of -2.17 sits in the grey zone, adding a manipulation concern. Net income of $124.7M was propped up by $186.4M in strategic investment gains and a $105.7M tax benefit, while stock-based compensation of $634.2M consumed 38% of gross profit.

The Public Safety Technology Platform

Axon's 10-K describes the company as a "diversified technology company" whose "integrated technology platform of hardware and software solutions advances our mission to (i) make the bullet obsolete, (ii) reduce social conflict, and (iii) enable a fair and effective justice system."

Revenue breakdown from the filing:

International revenue accounted for 17% ($474.5M), growing faster than domestic revenue. The company had approximately $9.9 billion of remaining performance obligations as of December 31, 2025 — the filing states: "As of December 31, 2025, we had approximately $9.9 billion of remaining performance obligations, which included both recognized contract liabilities and unbilled amounts."

Profitability: Headline Income Masks Underlying Weakness

The 10-K states: "Net income of $124.7 million included net realized and unrealized gains of $186.4 million related to our strategic investments and a $105.7 million tax benefit, partially offset by a net realized and unrealized loss of $46.4 million related to our marketable securities, inducement expense of $38.9 million associated with the early repurchase" of convertible notes, and "interest loss, net of $18.8 million."

Strip out the $186.4M investment gains and $105.7M tax benefit, and Axon's core operating profit is deeply negative. The company's net income dropped 67% despite 34% revenue growth — a major divergence.

Cash Flow: The Critical Red Flag

This is the first FAIL. Revenue grew 33.5% but operating cash flow declined 48.2%. The 10-K explains: "Net cash provided by operating activities was $211.3 million for the year ended December 31, 2025 compared to net cash provided by operating activities of $408.3 million for the year ended December 31, 2024."

The cash flow reconciliation reveals: net income of $124.7M, "a net add-back of non-cash income statement items of $568.4 million and a $481.7 million net change in operating assets and liabilities." Primary non-cash items include "$634.2 million of stock-based compensation expense for employee equity programs, $83.2 million of depreciation and amortization and $38.9 million" of debt inducement expense. But the $481.7M working capital drain consumed nearly half a billion dollars in cash as the company invested heavily in contract assets, prepaid supplier payments, and receivables growth.

CapEx surged 72.9% ($136.3M vs $78.8M), compressing free cash flow to just $75.1M — down 77% from the prior year despite 34% revenue growth.

Leverage: The Second Critical Red Flag

The company issued $1.75 billion of Senior Notes in March 2025. Per the filing: "As of December 31, 2025, we had an aggregate of $1.75 billion of Senior Notes outstanding." Total debt stands at $1.9B against cash and investments of $1.7B ($1.2B cash + $505.4M investments).

The debt load is massive relative to earnings. With Debt/EBITDA of 9.7x and negative interest coverage, the operating business cannot service its debt from current earnings. The 10-K discloses the company used "gross proceeds of $1.8 billion from the Senior Notes issuance and net proceeds of $489.6 million from our ATM equity offering program," partially offset by "$608.9 million of principal payments related to the conversions for our 2027 Notes."

The mitigating factor: Axon is not at immediate liquidity risk. But the capital structure has become aggressive for a company with $125M in net income.

Goodwill and Acquisitions: $1.6B and Growing

The filing shows goodwill grew from $756.8M to $1,370.2M. The 10-K states: "The goodwill associated with this business combination is primarily attributable to synergies that are expected to be achieved from the integration of the business and is not deductible for tax purposes." The company acquired Dedrone (drone detection technology) among other businesses.

Goodwill + intangibles total $1.6B, representing 48% of stockholders' equity — a watch item. "There were no accumulated impairment losses as of December 31, 2025 and 2024."

Goodwill + intangibles surged 68% YoY vs. 34% revenue growth — another watch item indicating the company is buying growth through acquisitions.

Stock-Based Compensation: $634M

SBC of $634.2M represents 23% of total revenue and 38% of gross profit. This is up from $382.6M in FY2024 and $131.4M in FY2023 — a nearly 5x increase in two years. The 10-K states the company has "historically granted and expect to continue to grant stock-based compensation to employees and non-employee directors as a means of attracting and retaining highly qualified personnel."

The 18-Point Screening

Beneish M-Score Component Breakdown:

The M-Score of -2.17 falls in the grey zone — between the -2.22 safe threshold and the -1.78 elevated manipulation risk threshold. The SGI (Sales Growth Index) of 1.335 reflects Axon's rapid revenue growth, which statistically correlates with higher manipulation risk. This does not mean Axon is manipulating earnings — but it warrants additional scrutiny.

Key Risks from the 10-K

1. Revenue-Cash Flow Divergence

Revenue grew 34% while operating cash flow declined 48%. Working capital consumed $481.7M in cash. This is the single most concerning signal — when a fast-growing company cannot convert revenue growth into cash, it may be pulling revenue forward or stretching operational capacity beyond what cash generation supports.

2. Aggressive Capital Structure

The $1.75B Senior Notes issuance tripled Axon's debt load. The company now has 9.7x Debt/EBITDA and negative interest coverage. The 10-K warns of risks associated with increased indebtedness.

3. Dependence on Law Enforcement Market

The 10-K warns: "We substantially depend on continued acceptance of our products and services by law enforcement agencies worldwide, and any reduction in demand could materially adversely affect our business." Political and regulatory risks around policing technology remain elevated.

4. Acquisition Integration Risk

With goodwill surging 81% in one year and FCF after acquisitions negative in 2 of 3 years, the company faces meaningful integration risk. The 10-K acknowledges risks of "write-downs or impairment of goodwill or other intangible assets if the acquired business underperforms expectations."

Key Financial Trends (4-Year)

Summary

Grade: F. Two critical red flags — revenue-cash flow divergence and leverage — require investigation.

Axon is delivering strong topline growth (34%) with a $9.9B RPO backlog, healthy 60% gross margins, and a leading position in public safety technology. The Altman Z-Score of 3.55 indicates no solvency concern.

But the financial quality is deteriorating. Operating cash flow dropped 48% while revenue surged 34% — a textbook revenue quality warning. Free cash flow collapsed 77% to just $75M. The $1.75B debt issuance pushed leverage to 9.7x EBITDA with negative interest coverage. Net income of $125M was artificially inflated by $186M in investment gains and $106M in tax benefits. And the Beneish M-Score of -2.17 sits uncomfortably in the grey zone.

The question for investors is whether Axon's cash flow decline is temporary — driven by working capital timing and investment in growth — or structural. If the $9.9B RPO converts to cash at historical rates, cash flow should normalize. But until it does, the data says: proceed with caution.

**Disclaimer**: This report is based on Axon Enterprise's fiscal year 2025 10-K filed with the SEC on February 25, 2026. This is NOT investment advice.

**About EarningsGrade**: We screen earnings reports for financial red flags using an 18-point forensic framework. Grade F means major red flags were detected that warrant thorough investigation.